Proteomics

Dataset Information

0

Alteration of protein expression and spliceosome pathway activity during Barrett’s carcinogenesis.

ABSTRACT: Esophageal adenocarcinoma (EAC) is a common and aggressive type of cancer and Barrett’s esophagus (BE) is a known precursor lesion and the strongest risk factor for EAC. Prediction of risk is currently based on histologic examination which is challenged by problems such as inter-observer variability due to high heterogeneity of the dysplastic tissue. Molecular markers might offer an additional way to understand carcinogenesis and improve diagnosis and eventually treatment. .

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Barrett's Esophagus, Stroma, Epithelial Cell

DISEASE(S): Esophagus Adenocarcinoma

SUBMITTER: Christoph Stingl  

LAB HEAD: Theo M. Luider

PROVIDER: PXD020903 | Pride | 2021-09-09

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
151112OFc1_CS-0777-e34-L213_192.raw Raw
151112OFc1_CS-0777-e34-L213_192fromEx-KMPox.v191126_151123OFc1_CS-0777-e34-L205_005and44more.mzid.gz Mzid
151112OFc1_CS-0777-e34-L213_192fromEx-KMPox.v191126_151123OFc1_CS-0777-e34-L205_005and44more.mzid_151112OFc1_CS-0777-e34-L213_192_from_Ex-KMPox.v191126__151123OFc1_CS-0777-e34-L205_005_and_44_more.MGF Mzid
151112OFc1_CS-0777-e34-L214_188.raw Raw
151112OFc1_CS-0777-e34-L214_188fromSx-KMPox.v200107_151123OFc1_CS-0777-e34-L204_009and45more.mzid.gz Mzid
Items per page:
1 - 5 of 273
altmetric image

Publications

Alteration of protein expression and spliceosome pathway activity during Barrett's carcinogenesis.

Stingl Christoph C   Bureo Gonzalez Angela A   Güzel Coşkun C   Phoa Kai Yi Nadine KYN   Doukas Michail M   Breimer Gerben Eise GE   Meijer Sybren Lodewijk SL   Bergman Jacques Johannes JJ   Luider Theo Marten TM  

Journal of gastroenterology 20210705 9

<h4>Background</h4>Barrett's esophagus (BE) is a known precursor lesion and the strongest risk factor for esophageal adenocarcinoma (EAC), a common and lethal type of cancer. Prediction of risk, the basis for efficient intervention, is commonly solely based on histologic examination. This approach is challenged by problems such as inter-observer variability in the face of the high heterogeneity of dysplastic tissue. Molecular markers might offer an additional way to understand the carcinogenesis  ...[more]

Similar Datasets

Transcriptomics Increased PXR and suppressed T-cell signaling are associated with malignant degeneration of Barrett’s esophagus
2023-01-08 | GSE210647 | GEO
Methylation profiling Global DNA methylation patterns in Barrett’s esophagus, dysplastic Barrett’s, dysplastic Barrett’s, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use
2016-10-25 | GSE89181 | GEO
Transcriptomics Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's
2017-07-23 | E-MTAB-4054 | biostudies-arrayexpress
Transcriptomics MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma
2010-05-16 | E-GEOD-16456 | biostudies-arrayexpress
Transcriptomics High fat diet accelerates Barrett esophageal carcinogenesis by inducing a distinct IL-8 dependent immune reaction through alteration of the microbiome
2019-04-30 | GSE103616 | GEO
Genomics MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma
2009-12-31 | GSE16456 | GEO
Transcriptomics Using DNA methylation to detect dysplasia/early neoplasia in Barrett's carcinogenesis
2013-01-28 | E-GEOD-32925 | biostudies-arrayexpress
Transcriptomics Gene expression data ARID1A knockdown OE33 cells versus mock OE33 cells
2012-06-01 | GSE38380 | GEO
Transcriptomics Gene expression data ARID1A knockdown OE33 cells versus mock OE33 cells
2012-05-31 | E-GEOD-38380 | biostudies-arrayexpress
Transcriptomics Copy number variation analysis of human Barrett's esophagus stem cells (HumanOmniZhongHua-8 v1.1 Beadchip)
2016-01-13 | E-GEOD-68663 | biostudies-arrayexpress